FDA Updates ALTUVIIIO Label with Full Pediatric Data in Hemophilia A
The US Food and Drug Administration (FDA) has approved an update to the label for Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl (ALTUVIIIO®) for pediatric hemophilia A based on data from the phase 3 XTEND-Kids study.1 Announced by …